Anurag Agrawal (medical scientist)

Anurag Agrawal joined the All India Institute of Medical Sciences, Delhi in 1989 for his MBBS after which he moved to the US for his residency at the Baylor College of Medicine where he also worked as a fellow at the Department of Pulmonary and Critical Care and as an assistant professor.

Subsequently, he joined the Institute of Genomics and Integrative Biology (IGIB) of the Council of Scientific and Industrial Research and served as the director.

[5] His interest in the interface of emerging technologies such as genomics and artificial intelligence with biology and medicine, led to his serving as co-chair of the Lancet and Financial Times commission on governing health futures 2030 and as a member of 'Responsible AI' subgroup of the Global Partnership for Artificial Intelligence (GPAI).

[6][7] During the COVID-19 pandemic, he led discovery of the Delta variant, served as co-chair of the World Health Organization (WHO) Technical Advisory Group for SARS CoV2 viral evolution and also as a member of the pathogens project of the Bulletin of the Atomic Scientists.

[8][9][10] Agrawal received the Lady Tata Young Researcher Award in 2010,[3] the same year as he was selected for the Swarnajayanthi fellowship of the Department of Biotechnology.